Skip to main content
. 2021 Jan 7;100(4):100941. doi: 10.1016/j.psj.2020.12.038

Table 6.

Antibiotic susceptibility among 329 SE isolates in 3 breeder farms.

Drugs No. of drug-resistant strains (%)
A n=144 B n=70 C n=115 Total n=329
β-Lactams AMP 93 (64.58) 52 (74.29) 45 (39.13) 190 (57.75)
AMC 68 (47.22) 14 (20.00) 1 (0.87) 83 (25.23)
CZO 15 (10.42) 4 (5.71) 8 (6.96) 27 (8.21)
MEM 3 (2.08) 3 (4.29) 0 (0) 6 (1.82)
ATM 14 (9.72) 3 (4.29) 7 (6.09) 24 (7.29)
Aminoglycosides KAN 0 (0) 4 (5.71) 6 (5.22) 10 (3.04)
GEN 0 (0) 4 (5.71) 1 (0.87) 5 (1.52)
STR 92 (63.89) 50 (71.43) 33 (28.70) 175 (53.19)
AMK 0 (0) 4 (5.71) 0 (0) 4 (1.22)
Quinolones CIP 15 (10.42) 57 (81.43) 3 (2.61) 75 (22.80)
ENR 66 (45.83) 33 (47.14) 3 (2.61) 102 (31.00)
NAL 143 (99.31) 69 (98.57) 105 (91.30) 317 (96.35)
Sulfonamides SXT 3 (2.08) 4 (5.71) 3 (2.61) 10 (3.04)
Chloramphenicols CHL 1 (0.69) 5 (7.14) 13 (11.30) 19 (5.78)
Nitrofurantoin NIT 134 (93.06) 12 (17.14) 2 (1.74) 148 (44.98)

Abbreviations: AMC, amoxicillin/clavulanic acid; AMK, amikacin; AMP, ampicillin; ATM, aztreonam; CHL, chloramphenicol; CIP, ciprofloxacin; CZO, cefazolin; ENR, enrofloxacin; GEN, gentamicin; KAN, kanamycin; MEM, meropenem; NAL, nalidixic acid; NIT, nitrofurantoin; SE, Salmonella Enteritidis; STR, streptomycin; SXT, trimethoprim/sulfamethoxazole.